These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11138697)

  • 21. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
    Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
    J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons.
    Pouget JP; Santoro L; Raymond L; Chouin N; Bardiès M; Bascoul-Mollevi C; Huguet H; Azria D; Kotzki PO; Pèlegrin M; Vivès E; Pèlegrin A
    Radiat Res; 2008 Aug; 170(2):192-200. PubMed ID: 18666820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
    Ginj M; Hinni K; Tschumi S; Schulz S; Maecke HR
    J Nucl Med; 2005 Dec; 46(12):2097-103. PubMed ID: 16330576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological toxicity of Auger emitters: molecular fragmentation versus electron irradiation.
    Hofer KG; Keough G; Smith JM
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):335-54. PubMed ID: 639556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
    Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorbed fractions for electrons and beta particles in spheres of various sizes.
    Siegel JA; Stabin MG
    J Nucl Med; 1994 Jan; 35(1):152-6. PubMed ID: 8271037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments.
    Goddu SM; Howell RW; Rao DV
    J Nucl Med; 1994 Feb; 35(2):303-16. PubMed ID: 8295004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [99mTc reduces clonogenic survival after intracellular uptake in NIS-positive cells in vitro more than 131I].
    Wendisch M; Freudenberg R; Drechsel J; Runge R; Wunderlich G; Kotzerke J
    Nuklearmedizin; 2010; 49(4):154-60. PubMed ID: 20490428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.
    Sharkey RM; Behr TM; Mattes MJ; Stein R; Griffiths GL; Shih LB; Hansen HJ; Blumenthal RD; Dunn RM; Juweid ME; Goldenberg DM
    Cancer Immunol Immunother; 1997 May; 44(3):179-88. PubMed ID: 9191878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-(125I)-iododeoxyuridine and the Auger effect: biological consequences and implications for therapy.
    Bloomer WD; Adelstein SJ
    Pathobiol Annu; 1978; 8():407-21. PubMed ID: 364377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steps towards cancer therapy with radionuclides--a review including radiation biophysical aspects.
    Kampf G
    Radiobiol Radiother (Berl); 1990; 31(3):215-29. PubMed ID: 2201055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A compilation of microdosimetry for uniformly distributed Auger emitters used in medicine.
    Chen J
    Int J Radiat Biol; 2008 Dec; 84(12):1027-33. PubMed ID: 19061126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
    Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
    J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
    Boyd M; Sorensen A; McCluskey AG; Mairs RJ
    J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radionuclide-antibody conjugates for single-cell cytotoxicity.
    Mattes MJ
    Cancer; 2002 Feb; 94(4 Suppl):1215-23. PubMed ID: 11877748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Auger electron dosimetry of indium-111 in mammalian cells in vitro.
    McLean JR; Blakey DH; Douglas GR; Bayley J
    Radiat Res; 1989 Aug; 119(2):205-18. PubMed ID: 2756113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphoma.
    Du Y; Honeychurch J; Glennie M; Johnson P; Illidge T
    Cancer Res; 2007 Feb; 67(3):1335-43. PubMed ID: 17283171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
    Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
    J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunoconjugates in acute leukemia treatment: the future is radiant.
    Kotzerke J; Bunjes D; Scheinberg DA
    Bone Marrow Transplant; 2005 Dec; 36(12):1021-6. PubMed ID: 16247432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.